[go: up one dir, main page]

NO995763L - Farmasoeytiske sammensetninger av peptider som har lav opploeselighet i fysiologisk medium - Google Patents

Farmasoeytiske sammensetninger av peptider som har lav opploeselighet i fysiologisk medium

Info

Publication number
NO995763L
NO995763L NO995763A NO995763A NO995763L NO 995763 L NO995763 L NO 995763L NO 995763 A NO995763 A NO 995763A NO 995763 A NO995763 A NO 995763A NO 995763 L NO995763 L NO 995763L
Authority
NO
Norway
Prior art keywords
peptides
pharmaceutical compositions
low solubility
physiological medium
physiological
Prior art date
Application number
NO995763A
Other languages
English (en)
Other versions
NO323697B1 (no
NO995763D0 (no
Inventor
Peter Richardson
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP97108593A external-priority patent/EP0880968A1/en
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO995763D0 publication Critical patent/NO995763D0/no
Publication of NO995763L publication Critical patent/NO995763L/no
Publication of NO323697B1 publication Critical patent/NO323697B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/25Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/09Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO19995763A 1997-05-28 1999-11-24 Farmasoytiske sammensetninger som inneholder peptider med lav opploselighet i fysiologisk medium NO323697B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97108593A EP0880968A1 (en) 1997-05-28 1997-05-28 Pharmaceutical compositions of peptides having low solubility in physiological medium
EP97121246A EP0880969A1 (en) 1997-05-28 1997-12-03 Pharmaceutical compositions of peptides having low solubility in physiological medium
PCT/EP1998/003079 WO1998053844A1 (en) 1997-05-28 1998-05-26 Pharmaceutical compostions of peptides having low solubility in physiological medium

Publications (3)

Publication Number Publication Date
NO995763D0 NO995763D0 (no) 1999-11-24
NO995763L true NO995763L (no) 1999-11-24
NO323697B1 NO323697B1 (no) 2007-06-25

Family

ID=26145485

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19995763A NO323697B1 (no) 1997-05-28 1999-11-24 Farmasoytiske sammensetninger som inneholder peptider med lav opploselighet i fysiologisk medium

Country Status (26)

Country Link
US (1) US6331520B1 (no)
EP (2) EP0880969A1 (no)
JP (1) JP2002502384A (no)
KR (1) KR100552546B1 (no)
CN (1) CN1159062C (no)
AR (1) AR012868A1 (no)
AT (1) ATE252909T1 (no)
AU (1) AU743152B2 (no)
BG (1) BG64668B1 (no)
BR (1) BR9809708A (no)
CA (1) CA2291765A1 (no)
CZ (1) CZ298825B6 (no)
DE (1) DE69819322T2 (no)
DK (1) DK0984788T3 (no)
EA (1) EA002227B1 (no)
EE (1) EE04001B1 (no)
ES (1) ES2210772T3 (no)
IL (2) IL133176A0 (no)
NO (1) NO323697B1 (no)
NZ (1) NZ500777A (no)
PL (1) PL192647B1 (no)
PT (1) PT984788E (no)
SI (1) SI0984788T1 (no)
SK (1) SK284640B6 (no)
TR (1) TR199902865T2 (no)
WO (1) WO1998053844A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8343186B2 (en) 2004-04-06 2013-01-01 Arthrex, Inc. Fully threaded suture anchor with transverse anchor pin
EP1064934A1 (en) 1999-06-30 2001-01-03 Applied Research Systems ARS Holding N.V. GRF-containing lyophilized pharmaceutical composition
WO2001087322A2 (en) * 2000-05-17 2001-11-22 Bionebraska, Inc. Peptide pharmaceutical formulations
US20040229334A1 (en) * 2003-05-15 2004-11-18 Mendoza Christine B. Process for manufacture of nematode-extracted anticoagulant protein (NAP)
JP2010523501A (ja) * 2007-04-04 2010-07-15 セラテクノロジーズ インコーポレイティド Ghrh分子の医薬製剤
JP6224586B2 (ja) 2012-07-10 2017-11-01 武田薬品工業株式会社 注射用製剤
US9107853B2 (en) 2012-10-12 2015-08-18 L'oreal S.A. Compositions containing phenolic compounds and hydrotropes for cosmetic use
US9018177B2 (en) 2012-10-12 2015-04-28 L'oreal S.A. Cosmetic compositions for increasing bioavailability of the active compounds baicalin and/or vitamin C
US9072919B2 (en) 2012-10-12 2015-07-07 L'oreal S.A. Synergistic antioxidant cosmetic compositions containing at least one of baicalin and taxifolin, at least one of caffeine and nicotinamide, at least one of vitamin C and resveratrol and ferulic acid
US9023826B2 (en) 2012-10-12 2015-05-05 L'oreal S.A. Compositions containing adenosine and the hydrotropes caffeine and nicotinamide for cosmetic use
WO2014059228A1 (en) * 2012-10-12 2014-04-17 L'oreal Cosmetic compositions containing at least one hydrotrope and at least one active compound
US9669242B2 (en) * 2013-07-01 2017-06-06 L'oreal Compositions containing at least two phenolic compounds, a lipid-soluble antioxidant and at least one hydrotrope for cosmetic use
JP6634758B2 (ja) * 2015-09-25 2020-01-22 ニプロ株式会社 液体組成物及び凍結乾燥製剤
RU2736590C2 (ru) 2016-02-16 2020-11-18 Стронгбридж Даблин Лимитед Велдореотид, обладающий плохой растворимостью в физиологических условиях, для применения при лечении акромегалии, акромегалии со злокачественным новообразованием, экспрессирующих sst-r5 опухолей, диабета 2 типа, гипергликемии и опухолей, связанных с гормонами
TW202031283A (zh) 2018-09-20 2020-09-01 馬克 C 曼寧 穩定卡貝縮宮素鼻內製劑

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4563352A (en) * 1982-10-04 1986-01-07 The Salk Institute For Biological Studies Human pancreatic GRF
US4935491A (en) * 1987-08-24 1990-06-19 Board Of Regents, The University Of Texas System Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
EP0374120A3 (en) * 1988-12-13 1991-07-31 Monsanto Company Comosition for controlled release of polypeptides
DK0506792T3 (da) * 1989-12-21 1995-10-09 Novo Nordisk As Insulinpræparat, der indeholder nikotinsyre eller nikotinamid
AU653026B2 (en) * 1991-06-07 1994-09-15 Teikoku Seiyaku Kabushiki Kaisha Physiologically active polypeptide-containing pharmaceutical composition
US5487898A (en) * 1991-08-26 1996-01-30 Abbott Laboratories Compositions and method for the sublingual or buccal administration therapeutic agents
EP0601053B1 (en) * 1991-08-26 2000-10-25 Abbott Laboratories Compositions and methods for the sublingual or buccal administration of therapeutic agents
US5446025A (en) * 1992-06-12 1995-08-29 Abbott Laboratories Formulations and method of the percutaneous administration of leuprolide
EP0626170A3 (en) * 1993-05-10 1996-03-27 Sandoz Ltd Stabilization of pharmacologically active compounds in delayed release agents.
TW280770B (no) * 1993-10-15 1996-07-11 Takeda Pharm Industry Co Ltd
AU3562195A (en) * 1994-10-04 1996-04-26 Novo Nordisk A/S Preparations containing aspb28 human insulin and nicotinamide
KR100236393B1 (ko) * 1996-02-02 1999-12-15 나까니시 히로유끼 사람성장호르몬을 함유하는 의약제제

Also Published As

Publication number Publication date
AU8106298A (en) 1998-12-30
PL336982A1 (en) 2000-07-31
EP0880969A1 (en) 1998-12-02
TR199902865T2 (xx) 2000-05-22
NZ500777A (en) 2001-09-28
EA199901089A1 (ru) 2000-06-26
EE9900545A (et) 2000-06-15
CN1159062C (zh) 2004-07-28
ATE252909T1 (de) 2003-11-15
DK0984788T3 (da) 2004-03-08
NO323697B1 (no) 2007-06-25
CZ423199A3 (cs) 2000-05-17
AR012868A1 (es) 2000-11-22
AU743152B2 (en) 2002-01-17
BG64668B1 (bg) 2005-11-30
PL192647B1 (pl) 2006-11-30
EA002227B1 (ru) 2002-02-28
SI0984788T1 (en) 2004-02-29
WO1998053844A1 (en) 1998-12-03
CA2291765A1 (en) 1998-12-03
SK159799A3 (en) 2000-07-11
DE69819322T2 (de) 2004-07-29
IL133176A (en) 2006-08-01
EP0984788A1 (en) 2000-03-15
CN1263469A (zh) 2000-08-16
KR20010012253A (ko) 2001-02-15
PT984788E (pt) 2004-01-30
NO995763D0 (no) 1999-11-24
SK284640B6 (sk) 2005-08-04
ES2210772T3 (es) 2004-07-01
CZ298825B6 (cs) 2008-02-20
BR9809708A (pt) 2000-07-11
KR100552546B1 (ko) 2006-02-14
HK1029928A1 (en) 2001-04-20
US6331520B1 (en) 2001-12-18
EP0984788B1 (en) 2003-10-29
JP2002502384A (ja) 2002-01-22
EE04001B1 (et) 2003-04-15
BG103884A (en) 2000-07-31
IL133176A0 (en) 2001-03-19
DE69819322D1 (de) 2003-12-04

Similar Documents

Publication Publication Date Title
NO995763L (no) Farmasoeytiske sammensetninger av peptider som har lav opploeselighet i fysiologisk medium
NO20002118D0 (no) Cykliske aminosyrer og derivater derav som er nyttige som farmasøytiske midler
IL202633A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
EP1156809A4 (en) OPHTHALMOLOGICAL PREPARATION THAT CONTAINS MUCIN
NO20004540D0 (no) Sammensetninger av peptider, formuleringer og anvendelse derav
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
ITRM960810A0 (it) Composizioni farmaceutiche contenenti ciclosporine o macrolidi
NO992339L (no) Farmasöytiske formuleringer
FIU20000164U0 (fi) Uusi farmaseuttinen formulaatio
BR9809468B1 (pt) Formulações farmacêuticas contendo voriconazol
NO20021780L (no) Bicykliske aminosyrer som farmasöytiske midler
PT1242087E (pt) Composicoes farmaceuticas
ITMI20001732A0 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti
DK1194153T3 (da) Smagsmaskerede flydende farmaceutiske formuleringer
HUP0001269A3 (en) 2-oxo-1-azetidine sulfonic acid derivatives and combined pharmaceutical compositions thereof
NO984878D0 (no) Fremstilling og anvendelse som medikamenter av 3-alkoksypyridin-2-karboksylsyreamidestere
DK0826375T3 (da) Anvendelse af komplekse lipider som stabiliserende tilsætningsstoffer til farmaceutiske præparater af fordöjelsesenzymblandinger
NO953367L (no) Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler
DE60019960D1 (de) Herstellung von isobutencopolymere
NO20006646D0 (no) Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel
EP1311239A4 (en) ORAL PEPTIDE ADMINISTRATION
EE9900260A (et) Ravimkompositsioonid külmkuivatamiseks
EE9900440A (et) Farmatseutilised kompositsioonid
ATE222586T1 (de) Benzolsulfonamidderivate und verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
EE200000330A (et) Farmatseutilised kompositsioonid

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS